ERBB2 and breast carcinoma: Recently, HER2-overexpressing human breast cancer cells have been evidenced to induce greater expression of Snail, Slug, and ZEB1 transcription factors, greater TGF-β production, and increased level of N-cadherins, followed by a decrease in expression of E-cadherin and cytokeratin-18 [30].